The mission of Aytu “A-2” BioPharma is to improve the lives of patients everywhere, with a distinct focus on complex CNS conditions. Our novel therapeutics enhance the lives of patients living with major depressive disorder (MDD) and attention deficit/hyperactivity disorder (ADHD). We ensure access to our medicines by thinking differently and acting boldly – while always putting patients first.
Overview
Our Mission, Vision, & Values
Leadership
Governance & Compliance
Partnering
Contact
Overview
EXXUA™
ADHD Portfolio
Legacy Portfolio